CD163 and neoplasm: The density of CD163(+) TAM was strongly associated with adverse outcomes such as tumor invasion, lymphatic metastasis, and hematogenous metastasis, and varied in tissues from different sites, whereas CD68(+) had no effect on tumor outcomes.